Use of ezetimibe results in more patients reaching lipid targets without side effects
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F14%3A10286927" target="_blank" >RIV/00216208:11110/14:10286927 - isvavai.cz</a>
Alternative codes found
RIV/00064165:_____/14:10286927
Result on the web
<a href="http://dx.doi.org/10.1016/j.crvasa.2014.01.006" target="_blank" >http://dx.doi.org/10.1016/j.crvasa.2014.01.006</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.crvasa.2014.01.006" target="_blank" >10.1016/j.crvasa.2014.01.006</a>
Alternative languages
Result language
angličtina
Original language name
Use of ezetimibe results in more patients reaching lipid targets without side effects
Original language description
In patients referred to the lipid clinic (typically because of side effects or failure to reach targets on other lipid-lowering therapy) treatment with ezetimibe significantly increased proportion of those achieving their target lipid levels. This was not accompanied by significant side effects.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FA - Cardiovascular diseases including cardio-surgery
OECD FORD branch
—
Result continuities
Project
—
Continuities
N - Vyzkumna aktivita podporovana z neverejnych zdroju
Others
Publication year
2014
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Cor et Vasa
ISSN
0010-8650
e-ISSN
—
Volume of the periodical
56
Issue of the periodical within the volume
2
Country of publishing house
CZ - CZECH REPUBLIC
Number of pages
5
Pages from-to
"e128"-"e132"
UT code for WoS article
—
EID of the result in the Scopus database
—